HB1796 amends Illinois’ Code of Civil Procedure to create a specific statute-of-limitations framework for product liability claims involving medical joint replacement products. The bill adds a special rule stating that strict-liability product claims involving a medical joint replacement generally must be brought within the existing limitations period and within 15 years of the product’s first installation, unless the manufacturer or seller expressly warranted the product for a longer period. It also preserves a discovery-based filing window for certain injuries, deaths, or property damage tied to a medical joint replacement, allowing suit within 4 years after the claimant knew or should have known of the harm, but no later than 8 years after the harm occurred.
The measure is narrowly focused on medical joint replacement products, while leaving the broader product-liability statute in place for other products. It would modify the timing rules in Section 13-213 of the Code of Civil Procedure and create a distinct limitations period for these devices, affecting injured patients, manufacturers, sellers, and insurers involved in joint replacement litigation. The bill appears designed to limit long-tail liability exposure for these products while still allowing claims to proceed within specified time windows.
Impact
HB1796 would amend Section 13-213 of the Illinois Code of Civil Procedure, which governs product liability actions based on strict liability in tort. The bill adds a new subsection specifically for medical joint replacement products, establishing a 15-year outside limit from first installation and a 4-year discovery period for certain claims arising within defined timeframes, subject to an 8-year cap from the date of injury or damage. In practice, this would create a special statute of repose/limitations rule for joint replacement devices and could bar older claims that would otherwise be pursued under general product-liability timing rules.
Sentiment
Because there are no committee transcripts or recorded votes provided, the public or legislative sentiment cannot be measured directly from the available history. Based on the bill text and caption, the measure appears to be a targeted liability-reform proposal rather than a broad policy change. Its structure suggests support from those seeking predictability and limits on long-term product-liability exposure, while likely drawing concern from plaintiffs’ advocates and injured patients who may view the new time limits as restricting access to court.
Contention
The main point of contention is likely the balance between limiting manufacturer/seller exposure and preserving injured plaintiffs’ ability to sue when harm from a medical joint replacement emerges years later. Supporters would likely favor the bill’s 15-year cap and clearer filing deadlines as a way to reduce stale claims and litigation uncertainty. Opponents would likely argue that joint replacement injuries can surface slowly, making a fixed repose period and the 8-year outer cap too restrictive for patients whose injuries are discovered late. Another possible issue is the bill’s special treatment of medical joint replacement products compared with other products, which may be seen as either a necessary carveout or an arbitrary distinction.